NCT02366819 2026-03-30
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
University of Chicago
Phase 4 Suspended
Clinical Trials
9 trialsNCT07446465 2026-03-03
FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
Fudan University
Phase 4 Not yet recruiting
NCT07094893 2026-01-14
ARIEL-ENGIC
Gruppo Oncologico del Nord-Ovest
Phase 4 Not yet recruiting
NCT06010277 2023-08-24
FLEX
Amphia Hospital
Phase 4 Unknown
NCT01271582 2019-01-29
Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients
Asan Medical Center
Phase 4 Unknown
NCT01588990 2019-01-22
ASCENT
Hoffmann-La Roche
Phase 4 Completed
NCT03084809 2017-03-21
Chemotherapy Combined With CIK Treating Colon Cancer
China Meitan General Hospital
Phase 4 Completed
NCT02284529 2014-11-06
Oxaliplatin
Sinphar Pharmaceutical Co., Ltd
Phase 4 Completed
NCT00559676 2011-05-16
Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 4 Completed